These findings provide novel insight into the immune‐metabolic regulation of lung injury and highlight NOD1 as a potential target for modulating inflammation in obesity‐related respiratory diseases. This evidence concerns the gene NOD1 and obesity due to melanocortin 4 receptor deficiency.